forecast

Regulation Keeps M&A in Hands of Incumbents

Because nicotine products increasingly require FDA or other regulatory approval, new entrants face high barriers, so the industry will be dominated by well-funded incumbents that can navigate approvals, and Evan expects little M&A from here.

forecastpending

Speaker

Evan

Evidence Quote

“I think it's going to continue to be dominated by the companies that have the money and the time and the regulatory prowess”

Source

British American Tobacco: Clearing the Air— Business Breakdowns
Created: 11/17/2026, 4:57:50 PM

Your notes

Loading notes...